ALEXANDER JANSONS MYOCARDITIS UK
The charity raises funds to finance research into the causes, diagnosis, treatment and prevention of myocarditis
Financial health, per its FY2025 accounts
The accounts state that unrestricted reserves stood at £126,701, with no reserves policy target required as salary costs are covered by trustee donations. The charity reports a net income of £30,345 and confirms it is a going concern with sufficient net assets to continue operations.
What the accounts disclose
“No level of reserves are required to be held as salary costs are covered by trustee donations.”
“In the period, £28,650 (2024: £26,262) was donated by one trustee and this donation was restricted to cover payroll costs.” — page 15
Trustees
- ANDY JANSONSchair
- Amanda Wilsher
- Derek Wilsher
- Pamela Jansons
- Tomas Jansons
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £93k | £63k |
| 31/12/2024 | £104k | £74k |
| 31/12/2023 | £198k | £179k |
| 31/12/2022 | £171k | £207k |
| 31/12/2021 | £93k | £39k |
Common questions
Is ALEXANDER JANSONS MYOCARDITIS UK financially healthy?
Per its FY2025 accounts: The accounts state that unrestricted reserves stood at £126,701, with no reserves policy target required as salary costs are covered by trustee donations. The charity reports a net income of £30,345 and confirms it is a going concern with sufficient net assets to continue operations. Its FY2025 accounts were independently examined.